Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
InventisBio
279
InventisBio
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Suggest edits
Founded
2013
Raised
$236M
Follow us
Also headquartered in Shanghai
Solar Power Inc.
Ctrip
Nio
Gobi Partners
Pinduoduo
Metaverse
Yuneec
Ele.me
Sina
NIO
Companies in the same industry
Genomera
Abraxis BioScience
Coronado Biosciences
3P Biopharmaceuticals
Akarna Therapeutics
Thar Pharmaceuticals
EnBiotix, Inc.
Entegrion
Intensity Therapeutic
Zedi Zedira
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$147,000,000
Venture capital (Series D) - 2020
QiMing Venture Partners
Ltd
OrbiMed
+8
$70,000,000
Venture capital (Series C) - 2019
OrbiMed
Lilly Asia Ventures
Advantech Capital
+1
Team Size
1–10
Employees
I work here
Location
Shanghai
,
China
Headquarters
Explore Shanghai
$147,000,000
Venture capital (Series D)
FinSMEs
InventisBio Raises $147M in Series D Financing
FinSMEs
InventisBio Closes $70 Million USD Series C Financing
$19,000,000
Venture capital (Series B)
ChinaMoneyNetwork
,
PE HUB
,
AVCJ
OrbiMed Asia Leads $19M Series B Round In Biotech Start-Up InventisBio
Funding
Asia
Health
